Current Endemic Polio Countries and Circulation Status
As of the most recent authoritative assessments, only two countries have never interrupted wild poliovirus (WPV) transmission and are classified as endemic: Afghanistan and Pakistan. These countries continue to report sporadic cases, predominantly of type 1, alongside ongoing challenges in detection, vaccination coverage, and access. Outside these areas, countries previously classified as endemic have interrupted indigenous transmission, shifting to vaccine-derived poliovirus (VDPV) events or importations. This distinction is central to understanding current risk landscapes and long-term eradication strategy.
Global Polio Eradication Initiative and Endemic Certification Criteria
Certification Standards and Verification Process
The Global Polio Eradication Initiative (GPEI) uses stringent, evidence-based criteria to assess whether a country can be certified as having interrupted endemic transmission. Certification requires at least three consecutive years without detecting indigenous WPV, robust acute flaccid paralysis (AFP) surveillance with high-quality stool sampling, strong routine immunization, and responsive outbreak control. Independent verification by regional and international expert committees ensures conclusions are data-driven and objective. These thresholds provide stability and public confidence in the official status of each country.
Risk of Re-Introduction and Maintenance of Vigilance
Even after interruption, countries remain at risk of re-introduction through imported virus from endemic areas or under-immunized populations. Maintaining high-quality surveillance, rapid response capacities, and strong routine immunization is essential to prevent resurgence. The shift toward oral polio vaccine type 2 (OPV2) withdrawal and the introduction of inactivated polio vaccine (IPV) into routine programs further refine protection. Continuous investment in primary healthcare and community trust supports sustained protection and moves countries closer to formal certification.
Table: Status of Countries Historically Classified as Endemic
| Country or Area | Last Indigenous WPV Detection | Current Circulation Type | Notes |
|---|---|---|---|
| Afghanistan | 2021 (WPV1) | Endemic, ongoing circulation | Security and access constraints hinder full surveillance |
| Pakistan | 2023 (WPV1) | Endemic, ongoing circulation | Large urban outbreaks and environmental positives persist |
| Nigeria | 2016 (WPV1) | No endemic circulation; rare VDPV2 events | Long-term interruption verified, strong routine progress |
| Syrian Arab Republic | 2013 (WPV1) | VDPV2 outbreaks in under-immunized areas | Conflict-driven service gaps contributed to re-establishment |
| Democratic Republic of the Congo | 2020 (WPV1) | VDPV2 outbreaks in multiple provinces | Interruption of indigenous WPV confirmed, new VDPV challenges |
| Philippines | VDPV3 outbreak linked to Sabin strain | High-quality response halted further spread |
Differences Between Endemic, Interrupted, and Re-Estimated Transmission
An endemic country shows continuous, undetected or incompletely controlled indigenous transmission, whereas an interrupted country has stopped indigenous WPV for the required period. Re-established or vaccine-derived events do not automatically imply endemic status; they may reflect gaps in immunization or sewage surveillance. Clear communication of these nuances helps stakeholders understand risk levels, prioritize investments, and avoid misallocation of resources. Accurate classification guides partnership priorities and informs funding and technical support strategies.
Operational and Structural Challenges in Endemic Areas
Access, Security, and Routine Immunization Gaps
In Afghanistan and Pakistan, operational barriers such as conflict, mobile population flows, and inconsistent cold chain infrastructure complicate case detection and vaccination delivery. Weak routine immunization in some districts sustains susceptible cohorts, enabling continued transmission. Strengthening micro-planning, community engagement, and cross-border coordination has reduced but not eliminated residual risks. Sustained political commitment and localized accountability remain decisive factors in closing the final immunity gaps.
Surveillance, Laboratory, and Data Integration
High-quality AFP surveillance, environmental sewage testing, and timely laboratory confirmation form the backbone of credible status assessments. Challenges include underreporting in remote areas, delays in sample transport, and variability in data integration across health information systems. Investments in GIS mapping, digital tools, and trained workforce improve data reliability and speed of outbreak response. Transparent reporting builds confidence among partners and communities alike.
Strategic Roadmap and Long-Term Outlook
The Global Polio Endgame Strategy emphasizes interrupting all WPV transmission, containing certified virus stocks, and withdrawing OPV2 from routine use. Countries that have interrupted endemic transmission transition to maintaining sensitive surveillance and rapid outbreak response, while endemic countries focus on closing immunity gaps and strengthening health systems. The phased introduction of novel OPV2 and careful management of vaccine virus containment support this transition. Sustained financing, cross-sector collaboration, and community trust are essential to achieve and certify global eradication.
Implications for Countries No Longer Endemic
Countries that have interrupted indigenous transmission must maintain high routine immunization coverage, sensitive surveillance, and robust outbreak preparedness to prevent re-establishment. Imported cases and VDPV events highlight the need for swift detection and high-quality response. Integration of polio infrastructure into broader primary healthcare enhances resilience against future threats and ensures legacy gains are not lost. Continued vigilance and efficient resource use protect populations and support regional certification goals.
Conclusion and Key Takeaways
Endemic polio transmission remains limited to Afghanistan and Pakistan, where operational, security, and coverage challenges sustain ongoing circulation. Most formerly endemic countries have interrupted indigenous transmission, moving into maintenance and outbreak response modes. Certification requires multiple years of rigorous surveillance and documented interruption, supported by strong routine immunization and accountable governance. Continued investment, innovation, and community partnership are central to achieving a world free of polio and preventing future outbreaks.